{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:53:34Z","timestamp":1785858814199,"version":"3.56.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1007\/bf02156265","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T21:01:46Z","timestamp":1126818106000},"page":"394-397","source":"Crossref","is-referenced-by-count":47,"title":["Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis"],"prefix":"10.1097","volume":"33","author":[{"given":"Giuseppe","family":"d'Albasio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Trallori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Ghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Milla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Morettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"BF02156265_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(62)92080-9","volume":"1","author":"JH Baron","year":"1962","unstructured":"Baron JH, Connell AM, Lennard-Jones JE. Sulfasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet 1962;1:1094\u20136.","journal-title":"Lancet"},{"key":"BF02156265_CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/gut.5.5.437","volume":"5","author":"AP Dick","year":"1964","unstructured":"Dick AP, Grayson MJ, Carpenter RG. Controlled trial of sulfasalazine in the treatment of ulcerative colitis. Gut 1964;5:437\u201342.","journal-title":"Gut"},{"key":"BF02156265_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(65)90972-4","volume":"1","author":"JJ Misiewicz","year":"1965","unstructured":"Misiewicz JJ, Lennard-Jones JE, Connell AM. Controlled trial of sulfasalazine in maintenance therapy for ulcerative colitis. Lancet 1965;1:185\u20138.","journal-title":"Lancet"},{"key":"BF02156265_CR4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.14.12.923","volume":"14","author":"AS Dissanayake","year":"1973","unstructured":"Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulfasalazine (Salazopyrin). Gut 1973;14:923\u20136.","journal-title":"Gut"},{"key":"BF02156265_CR5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/gut.21.3.232","volume":"21","author":"AK Azad Khan","year":"1980","unstructured":"Azad Khan AK, Howes DT, Piris J. Optimum dose of sulfasalazine for maintenance treatment of ulcerative colitis. Gut 1980;21:232\u201340.","journal-title":"Gut"},{"key":"BF02156265_CR6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(77)90831-5","volume":"2","author":"AK Azad Khan","year":"1977","unstructured":"Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulfasalazine. Lancet 1977;2:892\u20135.","journal-title":"Lancet"},{"key":"BF02156265_CR7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM197309062891001","volume":"289","author":"KM Das","year":"1973","unstructured":"Das KM, Eastwood MA, McManus JPA. Adverse reactions during salicylazosulphapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 1973;289:491\u20135.","journal-title":"N Engl J Med"},{"key":"BF02156265_CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.1.5220.147","volume":"1","author":"G Watkinson","year":"1961","unstructured":"Watkinson G. Medical management of ulcerative colitis. Br Med J 1961;1:147\u201351.","journal-title":"Br Med J"},{"key":"BF02156265_CR9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/BF01296907","volume":"28","author":"SL Taffet","year":"1983","unstructured":"Taffet SL, Das KM. Sulfasalazine: adverse effects and desensitization. Dig Dis Sci 1983;28:833\u201342.","journal-title":"Dig Dis Sci"},{"key":"BF02156265_CR10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198012253032602","volume":"303","author":"U Klotz","year":"1973","unstructured":"Klotz U, Maier K. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. N Engl J Med 1973;303:1499\u20131502.","journal-title":"N Engl J Med"},{"key":"BF02156265_CR11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(81)90523-7","volume":"2","author":"N Campieri","year":"1981","unstructured":"Campieri N, Lanfranchi GA, Bazzocchi G. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet 1981;2:270\u20131.","journal-title":"Lancet"},{"key":"BF02156265_CR12","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","volume":"92","author":"LR Surtherland","year":"1987","unstructured":"Surtherland LR, Martin F. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctosigmoiditis, and proctitis. Gastroenterology 1987;92:1894\u20138.","journal-title":"Gastroenterology"},{"key":"BF02156265_CR13","first-page":"F45","volume":"26","author":"A Ireland","year":"1985","unstructured":"Ireland A, Selby WS, Barr GD. Azodisalicylate for the treatment of active ulcerative colitis (abstr). Gut 1985;26:F45.","journal-title":"Gut"},{"key":"BF02156265_CR14","first-page":"164","volume":"5","author":"M Campieri","year":"1984","unstructured":"Campieri M, Lanfranchi Ga, Brignola C. High-dose 5-aminosalicylic enemas in the treatment of ulcerative colitis. Intern Med 1984;5:164.","journal-title":"Intern Med"},{"key":"BF02156265_CR15","first-page":"1151","volume":"86","author":"GA Lanfranchi","year":"1984","unstructured":"Lanfranchi GA, Campieri M, Brignola C. Treatment of ulcerative colitis patients with high-dose 5-ASA enemas. Report of 2 years in an outpatient clinic (abstr). Gastroenterology 1984;86:1151.","journal-title":"Gastroenterology"},{"key":"BF02156265_CR16","first-page":"1412","volume":"88","author":"SB Hanauer","year":"1985","unstructured":"Hanauer SB, Schultz PA, Kirsner GB. Treatment of refractory proctitis with 5-aminosalicylic enemas (abstr). Gastroenterology 1985;88:1412.","journal-title":"Gastroenterology"},{"key":"BF02156265_CR17","first-page":"1449","volume":"90","author":"SB Hanauer","year":"1986","unstructured":"Hanauer SB, Schultz PA. efficacy of 5-ASA enemas for steroiddependent ulcerative colitis (abstr). Gastroenterology 1986;90:1449.","journal-title":"Gastroenterology"},{"key":"BF02156265_CR18","first-page":"612","volume":"80","author":"GB Barber","year":"1985","unstructured":"Barber GB, Lee DZ, Antonioli DA. Refractory distal ulcerative colitis responsive to 5-aminosalicylic enemas. Am J Gastroenterology 1985;80:612.","journal-title":"Am J Gastroenterology"},{"key":"BF02156265_CR19","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/0016-5085(85)90156-8","volume":"88","author":"LS Friedman","year":"1985","unstructured":"Friedman LS, Richter JM, Kirkham SE. 5-Aminosalicylic enemas in refractory distal ulcerative colitis. A randomized controlled trial (abstr). Gastroenterology 1985;88:1388.","journal-title":"Gastroenterology"},{"key":"BF02156265_CR20","first-page":"1447","volume":"92","author":"A Ireland","year":"1987","unstructured":"Ireland A, Jewell DP. Comparative trial of olsalazine and sulfasalazine for maintenance treatment of ulcerative colitis in remission (abstr). Gastroenterology 1987;92:1447.","journal-title":"Gastroenterology"},{"key":"BF02156265_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.287.6384.23","volume":"287","author":"MJ Dew","year":"1983","unstructured":"Dew MJ, Harries AD, Evans N. Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth. Br Med J 1983;287:23.","journal-title":"Br Med J"},{"key":"BF02156265_CR22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0016-5085(88)90677-4","volume":"94","author":"SA Riley","year":"1988","unstructured":"Riley SA, Mani V, Goodman MJ, Her ME, Dutt S, Turnberg LA. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 1988;94:1383\u20139.","journal-title":"Gastroenterology"},{"key":"BF02156265_CR23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0016-5085(88)90569-0","volume":"94","author":"WL Biddle","year":"1988","unstructured":"Biddle WL, Greenberger NJ, Swan JT, McPhee MS, Miner PB. 5-Aminosalicylic enemas: effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 1988;94:1075\u20139.","journal-title":"Gastroenterology"},{"key":"BF02156265_CR24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","volume":"1","author":"SC Truelove","year":"1956","unstructured":"Truelove SC, Richards WCD. Biopsy studies in ulcerative colitis. Br Med J 1956;1:1315\u20137.","journal-title":"Br Med J"},{"key":"BF02156265_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","volume":"1","author":"JH Baron","year":"1964","unstructured":"Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964;1:89\u201392.","journal-title":"Br Med J"},{"key":"BF02156265_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"P Peto","year":"1977","unstructured":"Peto P, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1\u201339.","journal-title":"Br J Cancer"},{"key":"BF02156265_CR27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF02555391","volume":"29","author":"M Campieri","year":"1986","unstructured":"Campieri M, Lanfranchi GA, Brignola C,et al. Retrograde spread of 5-aminosalicylic acid enemas in patients with active colitis. Dis Colon Rectum 1986;29:108\u201310.","journal-title":"Dis Colon Rectum"}],"container-title":["Diseases of the Colon & Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1007\/BF02156265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:58:34Z","timestamp":1785855514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003453-199033050-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990]]}},"URL":"https:\/\/doi.org\/10.1007\/bf02156265","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}